Muna buƙatar ingantaccen dabarun kiwon lafiyar jama'a don cutar ta Covid na yanzu. Babban batun shine akwai ɗimbin martani ga duka cututtukan Covid da alluran rigakafi dangane da nau'ikan ilmin halitta, kwayoyin halitta da yanayin kiwon lafiya na mutane. Rasa daga manufofin yanzu shine fitarwa da goyan bayan hanyoyin likita na keɓaɓɓen.
Tarihin likitanci ya gaya mana hikimar sanya maganin ya dace da mutum. Wannan shi ne ginshiƙin abin da ake kira keɓaɓɓen magani ko na mutum. Kwararrun likitoci kuma suna samun haɗin magunguna don magance rashin lafiya ko cuta. Wannan ya bambanta da yawan amfani da kashe-kashe, girman-daya-ya dace da duk magunguna. Ana ba da shawara anan wata hanya ce ta tela ko ƙwararrun hanyoyin likitanci ga ɗaiɗaikun ilimin halitta da halayen halitta, da buƙatun likita da yanayi.
A matsayin misali na yadda ƙoƙarin sa jama'a su karɓi maganin jama'a shine batun rigakafin mura na yanayi. Babban juzu'in jama'a baya dauke su. A lokacin kakar 2019-2020, 63.8% na yara tsakanin watanni shida zuwa shekaru 17 sun sami allurar mura. A cikin manya, kawai 48.4% na mutane sun sami allurar mura.
Me yasa wannan? Domin sanin kowa ne cewa ingancinsu ya yi ƙasa kaɗan. Matsakaici, mutanen da suka yi allurar mura suna tsakanin kashi 40% zuwa 60% na rashin yiwuwar kamuwa da cutar fiye da mutanen da ba a yi musu allurar ba. Gaskiyar ita ce, maganin mura na shekara-shekara bai dace da kowane mutum ba. Ko da yake akwai ƙananan shaidar likita cewa shan maganin mura yana haifar da haɗari ga lafiya. Amma mutane sun san cewa yawan masu kamuwa da mura ya yi ƙasa kaɗan. Mutane da yawa suna yin nazarin haɗari / fa'ida mai ma'ana, suna ƙarasa da cewa babu isassun fa'idodi. Wasu, musamman tsofaffi waɗanda ke da mummunan yanayin kiwon lafiya da yuwuwar tsarin garkuwar jiki mai rauni suna samun allurar mura na shekara-shekara. Tsarin kula da lafiyar jama'a ya ba da izinin keɓancewar tsarin rigakafin mura na yanayi.
Kuma ya bayyana, dangane da bayanan gwamnati, cewa ƙananan haɗarin kuma shine yanayin cutar ta Covid na yanzu. Ga mafi yawan mutanen da ke kamuwa da cutar Coronavirus ko dai yana nufin babu alamun cutar ko kuma kawai masu laushi waɗanda ba su da bambanci da mura ko mura mai tsananin sanyi, waɗanda ke wucewa cikin ƴan kwanaki. Anan shine ruwaito Gaskiya game da ƙarancin haɗarin mutuwa na Coronavirus ga mutane masu lafiya: "CDC ta nuna cewa kashi 94% na mutuwar da aka ruwaito suna da cututtuka da yawa, ta haka ne rage lambobin CDC da aka danganta ga COVID-19 zuwa kusan 35,000 ga duk kungiyoyin shekaru." Wannan ya bambanta da adadin da aka bayar da rahoton sama da 730,000 da ke da alaƙa da Covid. Abin da wannan ke nunawa shine babban bambance-bambancen yadda mutane ke amsa cututtukan Covid saboda bambance-bambance na asali.
Abin da mutanen da suka kamu da cutar Covid ke samu shine rigakafi na dabi'a ga wannan ƙwayar cuta wacce ke da yawan binciken likita da karatun asibiti sun nuna ya fi rigakafin rigakafi. Na ƙarshe ya ragu a cikin kimanin watanni shida, yayin da rigakafi na halitta yana dadewa kuma yana da mafi kyawun kariya daga sababbin bambance-bambancen.
Haɗin magunguna
Bayan yin maganin ya dace da majiyyaci, an kafa hikimar asibiti don amfani da haɗin magunguna. Kuma sau da yawa, a cikin wannan annoba, wasu likitocin suna amfani da haɗin gwiwa wanda ya ƙunshi fiye da magunguna daban-daban da kuma, musamman a asibitoci, magungunan da gwamnati ta amince da su. Har ila yau, ana amfani da su sosai suna da bitamin da kari. Fitaccen Dokta Peter McCollough ya kasance babban mai ba da shawarar yin amfani da shi daidaikun haduwa don magancewa da hana kamuwa da cutar Covid. Duk wannan shine madadin dabarar alurar riga kafi ga kowa da kowa.
A yau, duk wanda ba tare da aiki da yawa ba zai iya samun ɗimbin ka'idojin haɗin gwiwa don magancewa da hana Covid.
Damar da aka rasa an tattauna a farkon cutar
Tsakanin farkon watannin 2020 na annobar cutar da kuma bullar allurar rigakafin cutar a karshen shekarar 2020, an yi sha'awar amfani da tsarin da aka keɓance na magani don magance cutar.'
Yi la'akari da abin da Cibiyar Mayo don Magungunan Mutum ya ce martani ga Covid-19. Takardar ta yi bayani dalla-dalla wasu tsare-tsare da Mayo ke bi don magance cutar ta hanyar samun bayanan likitanci da za su iya haifar da keɓaɓɓen hanyoyin magance cutar. Wannan shine abin da Mayo ke son yi:
"Lokacin da COVID-19 ya bazu ko'ina cikin Amurka a cikin Maris 2020, Cibiyar Kiwon Lafiya ta Mayo ta Magance Magungunan Mutum cikin gaggawa ta ba da amsa don hanzarta bincike, haɓakawa, fassarar da aiwatar da gwaje-gwajen litattafai, jiyya na ceton rai da bincike. Yanzu, ƙungiyoyin masana kimiyya na haɗin gwiwa suna ci gaba da tona asirin asirin ƙwayar cuta, gami da yin amfani da fasahar zamani ta hanyar yin amfani da fasahar zamani ta hanyar yin amfani da fasahar zamani. tsarin rigakafi da lalata gabobin jiki, nama da tasoshin jini, yana barin wasu marasa lafiya da tasirin dogon lokaci.”
A watan Satumba na 2020 Labari yana da taken mai ban sha'awa "Yadda ake amfani da madaidaicin magani don keɓance maganin COVID-19 bisa ga kwayoyin halittar mara lafiya." Ga wasu sassa:
"A cikin 'yan shekarun nan, an inganta tsarin da ya shafi kwayoyin halitta na daidaitattun magunguna a matsayin makomar magani. "Dukkanmu" yunkurin da ya fara a shekarar 2015.
Amma makomar da aka yi zato bai haɗa da COVID-19 ba. A cikin gaggawar neman maganin COVID-19 da ingantattun hanyoyin kwantar da hankali, ingantattun magunguna ba su da mahimmanci. Me yasa wannan? Kuma wadanne irin gudunmawar da zai iya bayarwa?
Idan madaidaicin magani shine makomar magani, to aikace-aikacen sa ga cututtukan cututtukan gabaɗaya, musamman COVID-19, na iya zama mai mahimmanci. Amma rawar da ta taka ya zuwa yanzu ta takaita. Madaidaicin magani dole ne yayi la'akari fiye da kwayoyin halitta kawai. Yana buƙatar wani m "omic" hanya wanda dole ne ya tattara bayanai daga maɓuɓɓuka da yawa - bayan kwayoyin halitta kawai - kuma a ma'auni masu kama daga kwayoyin halitta zuwa al'umma.
Halin ya zama mai rikitarwa ga cututtuka masu yaduwa. Kwayoyin cuta da kwayoyin cuta suna da nasu kwayoyin halittar da ke mu’amala ta hanyoyi masu sarkakiya da kwayoyin halitta a cikin mutanen da suke kamuwa da su. The genome na SARS-CoV-2 da ke ƙarƙashin COVID-19 an jera su da yawa. An gano maye gurbinsa kuma an gano shi a duk duniya, yana taimaka wa masana ilimin cututtukan dabbobi su fahimci yaduwar cutar. Koyaya, mu'amalar da ke tsakanin SARS-CoV-2 RNA da DNA na ɗan adam, da tasirin tasirin kwayar cutar, har yanzu ba a san su ba. ”
Akwai damar fara tattara nau'ikan bayanan da za su ba da damar samun ingantaccen tsarin kula da magunguna - wanda ke da cikakkiyar masaniya game da hadaddun mu'amala tsakanin kwayoyin halitta da halayyar zamantakewa.
NIH na da Ya ce: "Cibiyoyin Kiwon Lafiyar Jama'a na Cibiyar Nazarin Lafiya ta Duniya ta ba da sanarwar haɓaka mai girma a cikin bayanan COVID-19 da ake samu a cikin madaidaicin bayanan magungunanta, yana ƙara martanin bincike daga ƙarin mahalarta sama da 37,000, da bayanan gano cutar da kuma bayanan jiyya daga kusan mahalarta 215,000 na kiwon lafiya na lantarki (EHRs) waɗanda suke a halin yanzu."
Kwararren germane zuwa dabarun cutar cuta na keɓaɓɓen ana kiransa pharmacogenomic. Yana da nazarin rawar kwayoyin halitta a cikin amsawar ƙwayoyi. Ya haɗu da ilimin harhada magunguna da ilimin halittu don gano yadda ƙirar halittar mutum ke shafar martanin su ga magunguna, gami da alluran rigakafi.
Yana magana ne game da tasirin da aka samu da kuma gadaje bambance-bambancen kwayoyin halitta akan martanin magunguna a cikin marasa lafiya ta hanyar daidaita abubuwan halittar mutum tare da shan magani ko maganin alurar riga kafi, rarrabawa, metabolism da kawarwa. Yana ma'amala da tasirin kwayoyin halitta da yawa akan amsawar magani da rigakafin.
Babban burin pharmacoogenomics shine haɓaka hanyoyi masu ma'ana don haɓaka maganin miyagun ƙwayoyi, gami da alluran rigakafi, dangane da genotype na marasa lafiya, don tabbatar da mafi girman inganci tare da ƙarancin illa.
Ta hanyar amfani da magungunan ƙwayoyi, makasudin shine cewa magungunan ƙwayoyi, ciki har da allurar rigakafi, na iya maye gurbin ko aƙalla abin da aka yi wa lakabi da "magunguna-daya-daidai-duk". Har ila yau, Pharmacogenomics yana ƙoƙari ya kawar da hanyar gwaji-da-kuskure na rubutawa, ƙyale likitoci suyi la'akari da kwayoyin halittar marasa lafiyar su, aikin waɗannan kwayoyin halitta, da kuma yadda wannan zai iya rinjayar tasiri na jiyya na yanzu ko na gaba (kuma inda ya dace, ba da bayani game da gazawar jiyya na baya).
Jaridar Agusta 2020 Labari An yi wa taken "Pharmacogenomics na COVID-19 therapies." Anan akwai kyakkyawan ra'ayi da bincikensa:
"Pharmacogenomics na iya ba da izinin keɓance waɗannan magungunan ta haka inganta inganci da aminci. … Pharmacogenomics na iya taimaka wa likitocin su zaɓi ma'aikatan layin farko masu dacewa da allurai na farko wanda zai yuwu a sami isassun bayyanar cututtuka a tsakanin marasa lafiya marasa lafiya; waɗanda ba za su iya samun gazawar maganin rashin tasiri ba. bambance-bambancen kwayoyin halitta na iya canza magunguna na hydroxychloroquine, azithromycin, ribavirin, lopinavir/ritonavir da yuwuwar tocilizumab, wanda a zahiri zai iya shafar amsawar asibiti da guba a cikin jiyya na COVID-19… Babban nasarorin da aka samu a fagen ilimin harhada magunguna shi ne maganin da ake amfani da shi don magance wani, mai saurin kisa, cuta mai saurin yaduwa: abacavir na HIV… A cikin rashin lafiya mai tsanani kamar COVID-19, pharmacogenetics zai kasance da amfani kawai idan an riga an sami sakamakon gwajin ƙwayoyin cuta (watau pre-emptive pharmacogenetic) ko kuma da sauri samuwa (watau gwajin da ba a tantance ba). Cutar ta COVID-19, ƙoƙarin haɗin gwiwa tsakanin al'ummomin kiwon lafiya sun fi kowane lokaci don haɓaka ingancin waɗannan jiyya tare da tabbatar da aminci ga wasu manyan gwaje-gwajen COVID-19 na ƙasa suna kimanta magunguna, waɗanda za su sanar da rawar alamun magunguna don amfani da asibiti a nan gaba.
Farashin NPR na Yuli 2020 show An yi wa taken "Bincike Kan Magungunan Keɓaɓɓen Yana iya Taimakawa Jiyya na COVID-19." An dauki wannan labari:
A duk fadin kasar Duk Shirin Binciken Mu da nufin keɓance jiyya na kowane nau'i, gami da jiyya waɗanda za a iya haɓaka don sabon coronavirus. Ya zuwa yanzu fiye da mutane 271,000 a duk fadin kasar sun yi rajista don raba bayanai tare da shirin. Dukkanmu mun fara ne a karkashin Shugaba Barack Obama a cikin 2015 kuma ya shafi cibiyoyi a fadin kasar.
"Wannan dama ce mai ban sha'awa ga mahalartanmu don yin tasiri kai tsaye kan bincike na COVID-19, suna kallon yadda shigarsu cikin wannan yunƙurin tarihi ke haifar da canji," in ji Dr. Elizabeth Burnside. "Wannan yunƙurin da aka mayar da hankali zai iya zama mahimmanci musamman ga membobin al'ummomin da galibi ba su da wakilci a cikin binciken kiwon lafiya kuma waɗanda za su iya tambayar fa'idar gaba ɗaya da na sirri na shiga bincike."
A taƙaice, akwai ingantacciyar sha'awar likita a farkon cutar don amfani da magani na musamman, wanda aka inganta magunguna da haɗin magunguna ga daidaikun mutane ko wasu ƙididdigar yawan jama'a. Manufar tsakiya ita ce rage yawan magunguna da magungunan rigakafi da mummunan halayen da mace-mace.
Amma abu daya ya bayyana a fili. Hanyoyin da aka keɓance don sarrafa cutar ta Covid ba hukumomin kiwon lafiyar jama'a ba su bi da su ba. Sun sanya albarkatu da fatansu tare da yawan alurar riga kafi, duka biyun ƙarfafawa, tilastawa da kuma ƙara umarni. Fatan mu yi wa kanmu allurar rigakafin wannan annoba ya rasa gaskiya.
Sabanin haka, wata hanya ta keɓantacce, wanda ɗaruruwan likitoci ke amfani da su, bisa jigon magunguna, bitamin da kari an fi toshewa fiye da tallafin da cibiyar kiwon lafiyar jama'a ke tallafawa.
Sabbin dabarun kiwon lafiyar jama'a da aka gabatar
Sashe na ɗaya: daidaikun mutane sun yanke shawara ko dai da kansu ko kuma tare da shawarar likitan su don a yi musu rigakafin Covid. Kuma yarda da abin da jami'an gwamnati suka yanke shine mafi kyawun maganin Covid don marasa lafiya da marasa lafiya.
Sashi na Biyu: daidaikun mutane sun zaɓi ƙwararren likita wanda, bisa ga iliminsu, horarwa, gogewa da sakamakon aikin asibiti masu nasara, suna ba da madadin alluran rigakafi da hanyoyin kiwon lafiya da gwamnati ta inganta ga marasa lafiya da marasa lafiya. Kwararren likita yana amfani da tarihin likitancin majiyyaci, yanayi, buƙatu da keɓaɓɓen yanayin ilimin halitta da kwayoyin halitta don cimma mafi kyawun keɓaɓɓen maganin likita.
Sabbin dabarun kiwon lafiyar jama'a, saboda haka, abubuwa biyu ne. Rigakafin da ake da shi ya zama mai da hankali ko kuma an daidaita shi don biyan buƙatun wani ɓangare na yawan jama'a. Tare da yin amfani da kashi na biyu babu wata sadaukarwa ta gaskiya ta kare lafiyar jama'a a cikin annoba.
Sashi na biyu na dabarun ya yi magana kai tsaye game da juriya ga rigakafin Covid da wasu Amurkawa ke yi.
Wannan hangen nesa ne na hankali wanda ya yi daidai da imani da 'yancin likita. Idan mutum ya yi imanin cewa akwai wasu fa'idodin kiwon lafiya na allurar Covid, to, aikin likitancin gargajiya yana goyan bayan amfani da su akan tsarin warkewa na mutum ɗaya. Wannan yanke shawara ce ta sirri na kyauta, watakila tare da tuntuɓar likitan su don yarda cewa haɗarin rigakafin Covid sun fi fa'idodin sa.
Hatsari da fa'idodi na iya dogara ne akan binciken sirri na samun bayanan likita akan alluran rigakafi. Ko kuma akan bayanai daga hukumomin gwamnati, galibi ba tare da shawara daga likitansu ba.
Ba za a yi watsi da shi yana ƙara munanan bayanai game da allurar rigakafin Covid da ke isa ga jama'a. Misali ɗaya na kwanan nan daga binciken likita da aka buga Labari shine "Binciken fa'idar farashi ya nuna a hankali sosai cewa akwai adadin adadin wadanda suka mutu sau biyar da aka danganta ga kowane allurar rigakafi da waɗanda ke da alaƙa ga Covid-19 a cikin mafi ƙarancin 65+ alƙaluma." Daga wannan binciken: a cikin "kwanaki takwas bayan allurar rigakafi (inda ranar sifili ita ce ranar rigakafin), kashi sittin na duk mutuwar bayan allurar ana ba da rahoton a cikin VAERS." Wannan binciken ya kammala: "Ba a san dalilin da ya sa ake yin wannan yawan alluran rigakafi ga dukan ƙungiyoyi ba, ana ba da izini, da kuma haɓakawa."
A cikin neman aiwatar da hikimar dacewa da magani ga mutum, yana buƙatar yarda da ilimin cewa babu mutane biyu, a fannin likitanci, ilimin halitta da ilimin halitta, daidai suke; wannan ba za a iya jayayya ba. Wannan shine dalilin da ya sa yin amfani da pharmacogenomic yana da rawar da zai taka. Duban matsakaicin sakamakon ƙididdiga na allurar rigakafi yana watsi da rashin mutunta ilimin halittu, yanayin likita, damuwa da buƙatu. Wannan overoverlling na rigakafi ne.
Amurkawa sun kasance suna son ganin kansu a matsayin mutane na musamman. Wannan yana fassara zuwa ayyukan likita. Alurar riga kafi ga kowa da kowa yayi watsi da kuma bata darajar wannan imani na al'ada na Amurkawa.
Har ila yau, akwai damuwa na halal cewa ba da izini ga harbi ba a dogara ne akan cikakken, sauƙin fahimtar gabatar da bayanai kan haɗari ga nau'ikan mutane daban-daban masu tarihin likita daban-daban ba.
Wadanda ke adawa da allurar suna da hakkin yin tambaya cewa hukumomin gwamnati ba su bi kimiyar likitanci sosai, bayanai da gogewa ba. Misali, ɗimbin wallafe-wallafen sun kammala cewa umarnin zama-a-gida, kulle-kulle da rufe fuska ba su yi tasiri ba wajen sarrafa tasirin cutar.
Kuma a yanzu akwai kwararan shaidu da ke nuna cewa wadanda aka yi wa allurar za su iya kamuwa da cututtuka da kuma yada cutar. "Muna da bayanai yanzu a cikin makon farko na watan Agusta daga Cibiyar Medicaid da Sabis na Medicare, wanda ke nuna cewa… sama da kashi 60 na tsofaffi sama da shekaru 65 a asibiti tare da Covid an yi musu allurar," in ji babban Dokta Peter McCullough kwanan nan.
Wannan yana zubar da amincin hukumomin kiwon lafiyar jama'a da ikonsu na likitanci kuma yana lalata amincin jama'a ga hukumomin tarayya na aiwatar da manufofin cutar.
Rashin kuskuren maganin magani guda ɗaya kawai
Idan gwamnati za ta ƙyale wani ɓangare na jama'a su zaɓi keɓaɓɓen magani don magance kamuwa da cutar ta Covid da wani ɓangaren don zaɓar rigakafin (da sauran ayyukan gwamnati) me yasa hakan bai dace da manufofin lafiyar jama'a ba? Dabarun kashi biyu za su zama masu mahimmanci yayin da gwamnati ke haɓaka ko ba da umarnin harbin ƙararrawa akai-akai cikin watanni ko shekaru.
Zaɓin yana da ma'ana idan, haƙiƙa, akwai keɓaɓɓen zaɓin jiyya ban da allurar rigakafin da za a iya samu daga wasu ƙwararrun likita. Tabbas, yanzu akwai ɗimbin littattafan likitanci akan ka'idojin magani ba kawai don warkewa ba har ma don hana kamuwa da cutar Covid. Daruruwan likitocin Amurka suna amfani da su sosai cikin nasara.
Kuma wasu bayanan da ke isar da jama'a kamar nasarar amfani da jigon ivermectin a Indiya da Indonesiya na ƙarfafa sha'awar wasu mutane don neman madadin hanyoyin magani. Haka kuma, 'yan majalisa 100 zuwa 200 sun yi amfani wannan na kowa.
Haka kuma, yanzu akwai kuma ɗimbin ɗimbin littattafan likitanci, waɗanda jama'a suka san shi, suna tallafawa tasirin rigakafin halitta da aka samu ta hanyar kamuwa da cuta ta Covid da ta gabata. Shawara ce ta hankali don yanke shawarar cewa rigakafin mutum ya isa kariyar likita ba tare da ɗaukar haɗarin rigakafin ba. Suna da haƙƙin neman ƙwararren likita wanda ya yarda da gaskiyar likita.
Iyakar abin da za a iya tunanin "rasara" don wannan hanyar ita ce masu yin rigakafin da ke da ƙaramin kasuwa.
Likitoci ya kamata su sami 'yancin ba majiyyatan shawarar ko dai su yi amfani da ka'idar jiyya ta magani ko kuma taimakawa rubuta rigakafi na halitta (tare da ingantaccen gwaji) don ba marasa lafiya damar rungumar aikin likita na keɓaɓɓen maimakon a yi musu alurar riga kafi.
A cikin wannan tsarin manufofin kashi biyu, na haɓaka zaɓi tsakanin keɓaɓɓen kariyar likita tare da allurar rigakafi, za a iya samun cikakkiyar kariya ga dukkan jama'a ba tare da sadaukar da ƴancin likita ba kuma ba tare da wasu nau'ikan umarnin alluran rigakafi ba. Kiwon lafiyar jama'a baya buƙatar cikakkiyar amincewar jama'a na maganin magani guda ɗaya.
Wannan dabarar ta yi daidai da abin da likitoci da yawa suka faɗa a farkon cutar. Wato wannan rigakafin ya kamata a yi niyya ga waɗanda ke da mafi girman haɗarin mummunan tasirin Covid, ba duka jama'a ba. Sanin kowa ne a wurin jama'a kuma hukumomin kiwon lafiya sun yarda cewa wannan annoba ba ta haifar da babbar barazana ta rashin lafiya ko mutuwa ga mutanen da ba su wuce shekaru 70 ba, sai dai idan suna da cututtuka masu tsanani ko kuma cututtuka masu tsanani. Adadin mace-macen kamuwa da cuta ga yawancin jama'a ba sa gardamar allurar.
Yawancin jama'a suna so kuma sun cancanci zaɓi don amfani da wani abu banda allurar rigakafi don kare kansu. Wannan zaɓin zai fara aiki ne kawai idan gwamnati ta ba da izini da kuma tallafa wa ƙwararrun likitocin don baiwa majiyyatan su madadin alluran rigakafi.
Anan ga gaskiyar ɗa'a da likitanci: Kare lafiyar mutum ɗaya yana kare lafiyar jama'a amma bai sabawa kare lafiyar jama'a ba. Ayyukan kiwon lafiyar jama'a da suka wuce gona da iri, kamar umarnin alurar riga kafi, sabani ne don kare lafiyar mutum ɗaya ga mutane da yawa waɗanda ke tsoron ko da rashin yiwuwar mummunan sakamako ga alluran rigakafi.
Anan shine gaskiyar likita ta ƙarshe: Lokacin da aka yi amfani da duk kimiyyar likitanci da hanyoyin da ake da su gabaɗaya to sakamakon shine kare lafiyar jama'a cikin aminci ba tare da sadaukar da 'yancin likita na likitoci da daidaikun mutane ba.
Dabarun na yanzu sun gaza
Yayin da muke gab da kusan shekaru biyu na magance wannan annoba, akwai ɗimbin shaidun da ke nuna cewa fifikon allurar rigakafi ya gaza sosai. Amurka ce ke da mafi yawan adadin mutuwar Covid a duniya. Har yanzu, bayan amfani da tsarin rigakafin jama'a, mutuwar mutane 2,000 na yau da kullun suna da alaƙa da kamuwa da cuta ta Covid. Kowane mako ana kirga mutane da yawa a matsayin mutuwar Covid fiye da mutane 3,000 da suka mutu a bala'in 9/11.
Ba za a yi watsi da ita ba ita ce mujallar da aka ambata binciken mai taken "Ƙara a cikin COVID-19 baya da alaƙa da matakan rigakafi a cikin ƙasashe 68 da larduna 2947 a Amurka."
Ci gaba da kamuwa da cututtukan da ke tsakanin waɗanda aka yi wa cikakken rigakafin suna ƙaruwa. Domin bayan kimanin watanni shida alluran rigakafin sun rasa tasiri sosai, musamman a kan bambance-bambancen. Kuma mutanen da ke da cikakken alurar riga kafi za su iya ɗauka da kuma yada cutar ta coronavirus.
Idan mutum yana son asusun farko na yadda likitocin Amurka suka rubuta mummunan tasirin maganin rigakafin Covid da na majiyyatan su, sannan karanta adadin su. rantsuwa.
Wani sabon dabarun kiwon lafiyar jama'a wanda ya daina bin allurar rigakafi mai ra'ayin mazan jiya na iya samun tallafin jama'a. Yanzu ne lokacin da za a ba da tallafi da tallafawa keɓaɓɓen magungunan da ake amfani da su kan cutar.
Haɓaka zaɓi shine mafi kyawun tsarin kula da lafiyar jama'a fiye da yin amfani da fa'ida na sarrafa cutar sankara wanda ya lalata rayuka da haifar da damuwa ta tunani da kuma asarar rayuka da yawa.
A waccan batu na ƙarshe, CDC yanzu ta gane cututtukan yanayi suna jefa mutane cikin haɗari mai tsanani don lokuta masu tsanani na Covid. Kwatanta pre-cutar cutar ta 2019 zuwa 2020 lokacin da aka sami sabbin maganganu miliyan 53 na bakin ciki a duniya, karuwar kashi 28%, kamar yadda aka ruwaito. The Lancet. Tabbas, haɓaka ƙarin zaɓin likita don magance Covid zai taimaka wa mutane su kasance cikin koshin lafiya ta hankali da ta jiki.
Juriya ga umarnin rigakafin bai kamata a kalli rashin kishin kasa ba ko kuma haifar da lahani ga wasu. Taimakawa magungunan keɓaɓɓen hanya hanya ce ta gujewa mummunan tasiri ga tattalin arzikin Amurka saboda tsauri, ƙa'idodin rigakafin da ba su da ƙarfi waɗanda ke tilastawa Amurkawa da yawa karɓar asarar aikin da ke haifar da amincin jama'a.
Kasancewa da rai, lafiya, da aminci tabbas burin dukan mutane ne. Muna da kayan aiki da yawa fiye da alluran rigakafi don taimakawa mutane cimma burinsu. Yanzu muna buƙatar cibiyar kiwon lafiyar jama'a don barin duk kayan aikin da za a zaɓa cikin 'yanci.
-
Dokta Joel S. Hirschhorn, marubucin Cutar Kwayar cuta da labarai da yawa kan cutar, ya yi aiki a kan al'amuran kiwon lafiya shekaru da yawa. A matsayinsa na cikakken farfesa a Jami'ar Wisconsin, Madison, ya jagoranci shirin binciken likita tsakanin kwalejojin injiniya da likitanci. A matsayinsa na babban jami’i a ofishin tantance fasaha na majalisar wakilai da kuma kungiyar gwamnonin kasa, ya jagoranci manyan nazari kan batutuwan da suka shafi kiwon lafiya; ya ba da shaida a zaman majalisar dattijai da majalisar wakilai sama da 50 kuma ya rubuta ɗaruruwan labarai da kasidu a manyan jaridu. Ya yi aikin sa kai na zartarwa a babban asibiti sama da shekaru 10. Shi memba ne na Associationungiyar Likitocin Amurka da Likitoci, da Likitoci na Farko na Amurka.
Duba dukkan posts
